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Abstract
Cartilage damage in osteoarthritis (OA) is considered an 
imbalance between catabolic and anabolic factors, favoring the 
catabolic side. W e assessed whether adenoviral overexpression 
of transforming growth factor-’  (TGF’ ) enhanced cartilage 
repair and whether TGF’ -induced fibrosis was blocked by local 
expression of the intracellular TGF’  inhibitor Smad7. W e 
inflicted cartilage damage by injection of interleukin-1 (IL-1) into 
murine knee joints. After 2  days, we injected an adenovirus 
encoding TGF’ . On day 4, we measured proteoglycan (PG) 
synthesis and content. To examine whether we could block 
TGF’ -induced fibrosis and stimulate cartilage repair 
simultaneously, we injected Ad-TGF’  and Ad-Smad7. This was 
performed both after IL-1-induced damage and in a model of 
primary OA. In addition to PG in cartilage, synovial fibrosis was
measured by determining the synovial w idth and the number of 
procollagen I-expressing cells. Adenoviral overexpression of 
TGF’  restored the IL-1-induced reduction in PG content and 
increased PG synthesis. TGF’ -induced an elevation in PG 
content in cartilage of the OA model. TGF’ -induced synovial 
fibrosis was strongly diminished by simultaneous synovial 
overexpression of Smad7 in the synovial lining. O f great interest, 
overexpression of Smad7 did not reduce the repair-stimulating 
effect of TGF’  on cartilage. Adenoviral overexpression of TGF’  
stimulated repair of IL-1- and OA-damaged cartilage. TGF’ - 
induced synovial fibrosis was blocked by locally inhibiting TGF’  
signaling in the synovial lining by simultaneously transfecting it 
w ith an adenovirus overexpressing Smad7.
Introduction
O steoarthritis (OA) is a degenerative jo int disease character­
ized by cartilage breakdown, synovial fibrosis, and bone spurs. 
An imbalance between catabolic and anabolic factors favoring 
the catabolic side is very likely involved in the pathological fea­
tures of OA.
Currently, many attem pts are being made to repair the carti­
lage that has been damaged in OA. One approach focuses on 
shifting the m etabolic imbalance back by stimulating the ana­
bolic side. Transform ing grow th factor-p (TGF-p) is one of the 
anabolic factors involved in cartilage maintenance and 
appears to be a good candidate fo r cartilage repair. TGF-p is 
a stim ulator of extracellular matrix production, like collagen 
type II and proteoglycan (PG), in chondrocytes and it down- 
regulates matrix-degrading enzymes [1]. High amounts of
TGF-’  are stored in healthy cartilage [2-6], whereas in O A  car­
tilage the expression of TGF-’  is reduced [7]. Injection of TGF- 
P into naive murine knee jo ints results in an increase in PG 
content of the articular cartilage [8]. Moreover, in murine 
experimental rheumatoid arthritis, injection of TGF-’  protected 
cartilage from PG loss [9]. In addition, TGF-’  counteracts the 
anabolic factor interleukin-1 (IL-1), which is a very potent 
inducer of cartilage degradation [1 0 ,11] both in vivo and in 
vitro [1,12-16]. These data indicate that TGF-’  has great 
potential as a tool for stim ulating cartilage repair.
To obtain suffic ient amounts of TGF-’  in the jo int for a pro­
longed period of time, an adenovirus can be used as a vehicle. 
In vitro, chondrocytes that are transfected w ith an adenovirus 
encoding TGF-’  responded by elevation of PG and collagen 
production [1 7]. W e  wanted to assess whether adenoviral 
overexpression of TGF-’  in the synovial lining could stimulate 
repair of damaged cartilage in vivo.
IL-1 =  interleukin-1; Luc =  luciferase; OA =  osteoarthritits; PBS =  phosphate-buffered saline; pfu =  plaque-forming unit; PG =  proteoglycan; TGF-’  
=  transforming growth factor-’
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Unfortunately, introducing high amounts of TGF-p into a knee 
jo int has adverse effects. Adm inistration of 20 ng TGF-p is 
already suffic ient to result in an increased cellularity of the syn­
ovial lining, expansion of fibroblast population in the synovial 
connective tissue, and continued collagen deposition [18]. 
Injection of high amounts of TGF-p, either as a bolus injection 
or via adenoviral transfection, results in marked hyperplasia of 
the synovium and chondro-osteophyte formation [8 ,18-21]. 
This illustrates that the use of TGF-p for cartilage repair can 
result in side effects that are deleterious for future therapeutic 
applications.
The aim of th is study was to use TGF-p as a cartilage repair 
factor but at the same time to prevent the TGF-p-induced 
fib ro tic  side effect. Therefore, we examined the effect of aden­
oviral overexpression of active TGF-p on cartilage repair and 
additionally studied whether simultaneous Sm ad7 overexpres­
sion could block TGF-p-induced fibrosis. Sm ad7 is an intrac­
ellular molecule that inhibits the TGF-p signaling pathway. 
TGF-p binds to its type II receptor, which then form s a complex 
w ith the type I TGF-p receptor.
Subsequently, the intercellular signaling molecule Sm ad2 or 
Sm ad3 gets phosphorylated, form s a complex w ith common 
Smad, Smad4, and shuttles to the nucleus fo r transcription 
[22]. Sm ad7 inhibits Sm ad2 and Sm ad3 phosphorylation, 
thereby preventing further signaling [23,24].
To both stimulate cartilage and block side effects, we took 
advantage of the fact that adenoviruses, once injected into the 
murine knee joint, transfect the synovial lining but do not pen­
etrate the cartilage [25]. W e co-transfected the synovial lining 
w ith an adenovirus overexpressing TGF-p and an adenovirus 
overexpressing Smad7. The transfected synovial lining cells 
w ill produce TGF-p but due to an intercellular signaling block 
caused by Smad7, w ill no longer respond to this factor.
W e show  that adenoviral overexpression of TGF-p results in 
increased PG content of the cartilage both after IL-1-induced 
damage and in a spontaneous model of experimental OA. In 
both cases, the TGF-p-induced fibrosis can be prevented by 
simultaneous Sm ad7 overexpression.
Materials and methods
Animals
C 5 7 B l/6  mice (10 weeks old) and STR/ort mice (4 weeks old) 
were used. M ice were kept in filter-top cages w ith woodchip 
bedding under standard pathogen-free conditions. They were 
fed a standard diet and tap water ad libitum. The local animal 
com m ittee had approved this study.
Stimulation of cartilage repair by TGF-p after IL-1 insult
To assess whether adenoviral overexpression of TGF-p could 
stimulate cartilage repair, we inflicted cartilage damage in 73 
C 5 7 B l/6  mice by intra-articular injection of 10 ng IL-1 (R&D
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Effectof adenoviraltransforming growthfactor-p (TGF-p) expression on 
proteoglycan (PG) synthesis and content in cartilage. (a) PG synthesis 
was measured by 35SO42- incorporation into patellar cartilage 4 days 
after interleukin-1 (IL-1) injection. (CPM =  counts per minute) PG syn­
thesis increased after IL-1 injection (p <  0.005), and this increase was 
boosted by TGF-p (p <  0.0005 compared with IL-1). (b) PG content of 
cartilage was measured by Safranin O staining intensity of the cartilage 
in Safranin O/Fast Green stained sections. The mean PG content of 
non-treated knee joints was set at 100%. After IL-1 exposure, a clear 
reduction in PG content was observed (p <  0.05). By adenoviral 
expression of TGF-p after IL-1-induced damage, the PG content of the 
cartilage was almost normal. Error bars display standard error.
Systems, Inc., M inneapolis, MN, USA). Two days after IL-1 
injection, PG synthesis w ill have reached a low point [11]. A t 
this time point, an adenovirus overexpressing active TGF-p 
(Ad-TGF-p223/225) was injected intra-articularly (plaque-form­
ing units [pfu] 107/6  |il) and compared w ith a contro l virus (Ad- 
del 70-3). Four days after the primary insult, 53  mice were 
used fo r patellae isolation fo r PG synthesis measurement by
35S O 42' incorporation. The other 20 mice were used for isola­
tion of whole knee jo ints fo r histology.
Blocking TGF-p-induced fibrosis
To block TGF-p-induced fibrosis, 24  C 5 7 B l/6  mice were 
injected intra-articularly w ith adenoviruses in the com binations 
of A d-TG F-p223/225 +  Ad-luciferase (Ad-luc), Ad-Sm ad7 +  Ad- 
luc, and Ad-TG F-p223/225 +  Ad-Sm ad7 (at a pfu of 0.5 x  107 
per adenovirus in 6 |il) or Ad-luc alone (at a total pfu of 107) as 
a control. A fte r 14 days, when synovial fibrosis can be 
observed histologically, knee jo ints were isolated for histology.
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F igure  2
Synovialfibrosis was assessed in knee joints 2 weeks after intra-articular injection of Ad-transforming growth factor-p (TGF-p) combined with Ad- 
luciferase or Ad-Smad7. As a measure of fibrosis, the synovial width opposite the growth plates in the femur was measured (a) In addition, the 
amount of cells staining positive in immunohistochemically stained sections for procollagen type I was calculated with a computerized imaging sys­
tem (b). The data are represented as an increase of the viral control. Histological representations of the measurements give an indication of actual 
thickness (c) and procollagen positive cells (d) There were no differences between viral and non-injected controls. TGF-p overexpression resulted in 
an increase in synovial thickness and number of procollagen type I-positive cells (p <  0.05). By co-expression with Smad7, most of the TGF-p- 
induced fibrosis was prevented (p <  0.05). Error bars display standard error.
Simultaneously stimulating cartilage repair and blocking 
of fibrosis
To make sure that Sm ad7 did not interfere w ith TGF-p-stimu- 
lated PG synthesis, we assessed whether stimulation of carti­
lage repair was not blocked by co-transfection w ith Ad- 
Smad7, and cartilage damage was again introduced in 48 
C 5 7 B l/6  mice by intra-articular injection w ith 10 ng IL-1. A fter 
2 days, mice were injected w ith adenoviruses in the com bina­
tions of Ad-TG F-p223/225 +  Ad-luc, Ad-TG F-p223/225 +  Ad- 
smad7, or Ad-luc alone. Four days after IL-1 injection, 24  mice 
were used for isolation of patellae for 35S O 42- incorporation 
measurements. A fte r 2 weeks, the other mice were used for 
isolation of knee jo ints for histological assessment of fibrosis.
Cartilage repair while blocking fibrosis in spontaneous 
OA
To test whether we could stimulate cartilage repair in a spon­
taneous experimental O A model while preventing fibrosis, we 
extended our experiment to STR/ort mice. STR/ort mice 
develop O A spontaneously and show  pathological changes by 
8 weeks of age. W e injected adenoviruses intra-articularly into 
the knee jo int of 24  4-week-old STR/ort mice and repeated 
this injection after 2 weeks. The adenoviruses were injected in 
the com binations of Ad-TG F-p223/225 +  Ad-luc, Ad-sm ad7 +  
Ad-luc, and Ad-TG F-p223/225 +  Ad-sm ad7 at a pfu of 0.5 x  1 0 7 
per adenovirus or Ad-luc at a pfu of 107 alone as a control. 
Four weeks after the first injection, knee jo ints were isolated
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F igure  3 F igure  4
Proteoglycan (PG) synthesis in patellarcartilage after exposure to both 
transforming growth factor-p (TGF-p) and Smad7. PG synthesis was 
measured by 35SO42- incorporation into patellar cartilage 4 days after 
interleukin-1 (IL-1) injection. (CPM =  counts per minute) Simultaneous 
injection of Ad-TGF-p and Ad-Smad7 significantly increased PG syn­
thesis compared with IL-1 + control virus (p <  0.005) and therefore did 
not block 35SO42- incorporation. Error bars display standard error.
fo r histological analysis of synovial fibrosis and PG content of 
the cartilage.
Histology
Knee jo ints of mice were dissected and fixed in phosphate- 
buffered formalin for 7 days. Thereafter, they were decalcified 
in 10%  form ic acid fo r 1 week. Knee jo ints were dehydrated 
w ith an automated tissue-processing apparatus (Tissue Tek 
VIP, Sakura, Ramsey, MN, USA) and em bedded in paraffin. 
Coronal whole knee jo int sections of 7 |im  were made. S ec­
tions were stained w ith Safranin O and Fast Green.
Immunohistochemistry
Sections were deparaffinized and washed w ith phosphate- 
buffered saline (PBS). For antigen unmasking, sections were 
incubated in citrate buffer (0.1 M sodium citrate +  0.1 M citric 
acid) for 2 hours. Endogenous peroxidase was blocked with 
1% hydrogen peroxide in methanol for 30  minutes. Thereafter, 
sections were blocked w ith 5%  normal serum of the species 
in which the secondary antibody was produced. S pecific  pri­
mary antibodies against procollagen type I (2 |ig /m l) (Santa 
Cruz B iotechnology, Inc., Santa Cruz, CA, USA) were incu­
bated overnight at 4°C. A fte r extensive washing w ith PBS, the 
appropriate biotin-labeled secondary antibody was used 
(DakoCytomation, G lostrup, Denmark) fo r 30 minutes at room 
tem perature fo llowed by a biotin-streptavidine detection sys­
tem according to m anufacturer's protocol (Vector Laborato­
ries, Burlingame, CA, USA). Bound complexes were visualized 
using DAB (3,3'-diam inobenzidine) reagent, counterstained 
w ith haematoxylin, dehydrated, and mounted w ith Permount.
PG synthesis
For measurement of PG synthesis, 35S O 42 was incorporated 
into isolated patellae. Immediately after isolation, the patellae 
were placed in D ulbecco's m odified Eagle's medium w ith gen-
Cartilagedam agewasintroducedby interleukin-1 (IL-1 ) injection, and 
2 days later transforming growth factor-ß (TGF-ß) was injected intra- 
articularly combined with Ad-luciferase or Ad-Smad7. Two weeks after 
adenoviral transfection, knee joints were isolated for assessment of 
fibrosis. (a) Synovial thickness had increased significantly (p <  0.005) 
after exposure to TGF-ß. The TGF-ß-induced increase was reduced by 
simultaneous overexpression of Smad7 (p <  0.05). (b) The number of 
procollagen type I-expressing cells had increased after TGF-ß expo­
sures accordingly (p <  0.0005). This was also partially blocked by 
Smad7 (p <  0.005). Error bars display standard error.
tamicin (50 mg/ml) and pyruvate. A fter half an hour, medium 
was replaced by medium containing 35S O 42 (20 |iC i/m l) and 
incubated for 3 hours at 37 °C  in 5%  C O 2. Patellae were then 
further prepared for measurement of 35S O 42 incorporation in 
the articular cartilage as previously described [26].
PG content
PG content was measured in sections stained w ith Safranin O 
and Fast Green, using a com puterized imaging system as pre­
viously described [27]. Briefly, Safranin O stains PGs in the 
cartilage red. The amount of PGs is determ ined by a com pu­
terized calculation of the amount of blue light passing through 
the red-stained cartilage. An increase in PGs leads to more 
intense red staining and reduced blue light passing through. 
The PG content of the tibia was calculated by the average of 
three sections per joint.
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Proteoglycan (PG) content of osteoarthritits (OA) cartilage in STR/ort 
mice. STR/ort mice (4 weeks old) were injected intra-articularly with 
Ad-transforming growth factor-p (TGF-p) combined with Ad-Smad7 or 
Ad-luciferase and injected again 2 weeks later. Four weeks after the 
first injection, knee joints were isolated and the effect of TGF-p overex­
pression on PG content was assessed. TGF-p exposure resulted in a 
significantly higher PG content of cartilage than luciferase-injected con­
trols (p <  0.05). Co-expression with Smad7 had no effect on the PG 
content. Error bars display standard error.
Measurement of fibrosis
Sections were stained im m unohistochemically fo r procollagen 
type I as a measure of fibrosis. Subsequently, the amount of 
cells that stain positive in the synovial tissue was determined. 
A  blinded observer selected the synovial tissue in three sec­
tions per knee joint. A  computerized imaging system subse­
quently determ ined the amount of positive cells in the selected 
area. The obtained values were averaged per knee joint.
In addition, synovial hyperplasia was assessed by measure­
ment of synovial thickness. This was determ ined in sections 
stained w ith Safranin O and Fast Green. The thickness of the 
synovial tissue was measured w ith a computerized imaging 
system again in three sections per knee jo int and averaged per 
jo int as previously described [27] (Qwin; Leica Imaging Sys­
tems Ltd., Cam bridge, UK). In short, the w idth of the jo int from 
bone edge to jo int capsule, minus the w idth of the jo int space 
itself, was determined.
Statistical analysis
Results were analyzed w ith a S tudent's t test and stated s ig ­
nificant if the p  value was lower than 0.05.
Results
Overexpression of TGF-p stimulates cartilage repair
Knee jo ints that are in jected w ith IL-1 initially show  a reduced 
incorporation of 35S O 42 into their patellar cartilage. A fte r 2-3 
days, this has reached a low point, and thereafter the incorpo­
ration rapidly increases above normal incorporation levels. By 
day 4, the incorporation of 35S O 42 had significantly increased 
to 165%  of the normal value (p <  0.005). On day 2, an aden­
ovirus encoding active TGF-p was injected into the knee joint. 
The TGF-p overexpression boosted the incorporation of
35S O 42 beyond the already elevated incorporation to 200%  of 
the normal value (Figure 1a). As a result, the overexpression of 
TGF-p after IL-1 injection almost com pletely restored the s ig ­
nificantly reduced PG content of cartilage (96%  of normal 
control, p  <  0 .0005) (Figure 1b). These data show  that aden­
oviral overexpression of TGF-p can stimulate cartilage repair.
TGF-p induces synovial fibrosis that can be blocked with 
Smad7
Intra-articular injection of Ad-TGF-p resulted in a significant 
increase of synovial thickness (2.5-fold the w idth of controls) 
2 weeks after injection. The percentage of cells expressing 
procollagen I increased accordingly (2.45-fold the amount of 
positive cells in controls) (Figure 2). By simultaneous overex­
pression of Ad-TGF-p and Ad-Sm ad7, the TGF-p-induced syn­
ovial thickness had been significantly reduced (p <  0.05). 
Sixty-five percent of the increased thickness and 65%  of the 
elevated number of procollagen I-positive cells had been 
blocked by co-expression of Sm ad7 (Figure 2). Smad 7 itself 
had no effect on synovial thickness or procollagen I expres­
sion. This illustrates that the TGF-p-induced fibrosis can be 
significantly blocked by co-transfection w ith Ad-Sm ad7.
TGF-p overexpression repairs cartilage while fibrosis is 
blocked with Smad7
To use the com bination of TGF-p and Sm ad7 as a potential 
therapeutic intervention, we had to make sure that Smad7 
overexpression did not interfere w ith the beneficial effect of 
TGF-p on cartilage repair. Therefore, TGF-p and Sm ad7 ade­
noviruses were in jected 2 days after IL-1 injection. This com ­
bination turned out to be beneficial for PG synthesis and could 
still induce a significant increase in PG synthesis (80%  
increase of PG synthesis com pared w ith IL-1 alone, p  <  
0.005). S imultaneously overexpressing Sm ad7 and TGF-p did 
not result in blocking of the repair-stimulating effects of TGF- 
p on cartilage (Figure 3).
Adenoviral overexpression of TGF-p resulted in a significant 
increase of 3.5 times as many cells expressing procollagen 
type I as the IL-1 contro l alone (p <  0.005). By co-expression 
of Smad7, 38%  of the increase was blocked (p <  0.005). The 
synovial tissue had expanded significantly to almost four times 
in w idth after TGF-p overexpression compared w ith IL-1 +  
contro l virus (p <  0 .0005). A lm ost half of the increase was s ig ­
nificantly blocked by simultaneous exposure of the synovial 
cells to TGF-p and Sm ad7 (p <  0 .005) (Figure 4).
These data show  that after IL-1 -induced cartilage damage, the 
TGF-p-induced fibrosis could still be blocked by Sm ad7 over­
expression w ithout interfering w ith the effect TGF-p elicits on 
cartilage.
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F igure  6
Blocking of transforming growth factor-p (TGF-p)-induced synovial fibrosis in osteoarthritits (OA). STR/ort mice (4 weeks old) were injected intra- 
articularly with Ad-TGF-p combined with Ad-Smad7 or Ad-luciferase (Ad-luc) and injected again 2 weeks later. Two weeks after the last injection, 
knee joints were isolated for histology and synovial fibrosis was assessed. Synovial thickness was determined by measuring the width of the syn­
ovium opposite the growth plates in the femur. (a) Synovial thickness had increased significantly after adenoviral TGF-p overexpression (p <  0.005). 
More than 50% of this increase in width was prevented by simultaneous expression of Smad7 (p <  0.005). The number of procollagen type I- 
expressing cells (b) had increased as well after exposure to TGF-p (p <  0.0005). This was also inhibited by more than 50% by co-expression of 
Smad7. Histological representations of the measurements give an indication of actual thickness (c) and procollagen positive cells (d) Error bars dis­
play standard error.
In experimental OA, simultaneous overexpression of 
TGF-p and Smad7 increased PG content of cartilage and 
prevented synovial fibrosis
The experiments conducted so far had been done in a rela­
tively simple model introducing cartilage damage by injection 
of IL-1. However, in O A we are dealing w ith a more complex 
situation. W e introduced com bined overexpression of TGF-p 
and Sm ad7 in STR/ort mice. These mice develop O A sponta­
neously; therefore, they can be used as a model of primary OA. 
In STR/ort mice, O A progresses relatively slowly. Therefore, 
we examined the final result of TGF-p and Sm ad7 overexpres­
sion 2 weeks after the second of (in total) two viral injections. 
STR/ort mice that had been injected w ith the adenovirus for 
TGF-p (com bined w ith a contro l virus) alone displayed a s ig ­
nificantly higher PG content in cartilage than did contro ls w ith ­
out TGF-p overexpression (p <  0.05) (Figure 5). However, 
these mice had massive synovial hyperplasia. The synovial 
thickness had increased significantly to 4.4 times the w idth of
non-injected controls, and almost every cell expressed proco l­
lagen type I (p <  0 .005) (Figure 6).
Com bining overexpression of TGF-p and Sm ad7 managed to 
maintain a significantly higher PG content in cartilage than 
contro ls (p <  0 .005) (Figure 5). More than half of the increased 
synovial thickening that had been caused by TGF-p was inhib­
ited significantly by overexpression of Sm ad7 (p <  0 .005). The 
amount of procollagen type I-positive cells had been reduced 
accordingly (Figure 6).
These data clearly indicate that PG synthesis can be stim u­
lated while inhibiting an increase of synovial fibrosis in an 
experimental model of OA.
Discussion
The cartilage damage in O A  is thought to be a consequence 
of a m isbalance between anabolic and catabolic factors, favor-
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ing the catabolic side. In this study, we used TGF-p as the ana­
bolic factor fo r cartilage repair. TGF-p has been reported to 
enhance periosteal chondrogenesis in explants in a dose- 
dependent manner [28 ]. Morales and colleagues [4,5] dem on­
strated that TGF-p increased PG synthesis and suppressed 
its degradation in articular cartilage organ cultures. In addition, 
van Beuningen and colleagues [8] showed that in vivo TGF-p 
injections result in prolonged elevation of PG synthesis and 
PG content of cartilage in mice. These studies indicate that 
TGF-p has good potential fo r repairing cartilage. W e showed 
that adenoviral overexpression of TGF-p was indeed able to 
boost cartilage repair in vivo. In vitro, it had already been 
shown that chondrocytes exposed simultaneously to IL-1 and 
TGF-p could reverse the IL-1-induced suppression of PG 
incorporation in their extracellular matrix [15]. Supportive of 
our findings, van Beuningen and colleagues [13 ] dem on­
strated that, in vivo, TGF-p also counteracted deleterious 
effects of IL-1 on cartilage PG synthesis and PG content. In 
the current study, we first damaged cartilage by IL-1 injection 
and subsequently overexpressed TGF-p. In this way, we could 
assess whether TGF-p was able to restore, instead of prevent, 
cartilage damage. W e introduced TGF-p via adenoviral over­
expression, thereby gaining prolonged high expression of 
TGF-p, instead of via a bolus injection that results in short 
TGF-p exposure. This way, we were able to demonstrate 
increased PG synthesis and higher PG content in cartilage not 
only in a clean setting introducing cartilage damage w ith IL-1 
but also in a spontaneous O A model.
The drawback of using TGF-p is that it can have adverse 
effects in joints. TGF-p is a known inducer of fibrosis in various 
tissues, and synovial tissue is no exception [8,21]. W e took 
advantage of the fact that adenoviruses transfect only the syn­
ovial lining. In addition, we profited from the fact that Sm ad7 is 
an intercellular inhibitor of TGF-p. Sm ad7 stays inside the cell 
that is transfected w ith the adenovirus encoding Smad7. 
Because the synovial lining is where TGF-p induces synovial 
fibrosis, by co-transfection w ith Smad7, the lining appeared to 
be less sensitive to TGF-p-induced fibrosis. The reduction of 
TGF-p-induced fibrosis was not optimal and resulted in only a 
partial block of the fibrosis. This is likely due to the fact that not 
all cells in the synovial lining will be targeted. By optim izing 
this, we m ight be able to target every single one of the synovial 
lining cells and thereby fully block the TGF-p-induced fibrosis.
W e have previously demonstrated that blocking TGF-p with 
Ad-Sm ad7 in O A resulted in reduction of the synovial fibrosis 
that was induced by the O A  process itself [27]. Now we com ­
bined the Sm ad7 adenovirus w ith Ad-TGF-p to block the TGF- 
p-induced fibrosis. W e  showed that the Ad-TGF-p transfec­
tion was still functional in combination w ith Smad7. Moreover, 
we dem onstrated fo r the first time that adenoviral overexpres­
sion of TGF-p could stimulate repair of damaged cartilage and 
that co-expression w ith Sm ad7 could prevent a great deal of 
the TGF-p-induced synovial fibrosis. Com bining Sm ad7 and
TGF-p resulted in a higher PG synthesis after IL-1 insult than 
did TGF-p alone. This is likely due to the reduced synovial 
fibrosis when com bined w ith Smad7.
Unfortunately, synovial fibrosis is not the only side effect of 
TGF-p overexpression in knee joints. TGF-p can induce oste­
ophyte formation [8 ,19 ,20,29-31]. In the case of OA, TGF-p 
can aggravate the osteophyte formation that already occurs. 
W e show  that it is possible to target synovial cells to prevent 
fibrosis. In a sim ilar fashion, we could potentially target the 
mesenchymal stem cells that eventually form the osteophytes 
after TGF-p exposure. This could be an option when key play­
ers of osteophyte formation are identified and can be blocked 
selectively.
Conclusion
W e dem onstrated that adenoviral overexpression of TGF-p 
increases PG synthesis and PG content in cartilage, even in 
experimental OA. In addition, co-transfecting the synovial lin­
ing w ith Ad-Sm ad7 can block the fibrosis that is induced by 
TGF-p overexpression.
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